Pro Share Advisors LLC Denali Therapeutics Inc. Transaction History

Pro Share Advisors LLC

  • $36.5 Billion
  • Q2 2024

A detailed history of Pro Share Advisors LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 24,798 shares of DNLI stock, worth $709,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,798
Previous 31,205 20.53%
Holding current value
$709,966
Previous $640,000 10.16%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$14.96 - $23.22 $95,848 - $148,770
-6,407 Reduced 20.53%
24,798 $575,000
Q1 2024

May 08, 2024
BUY
$15.83 - $23.35 $44,640 - $65,847
2,820 Added 9.93%
31,205 $640,000
Q4 2023

Feb 14, 2024
BUY
$16.2 - $23.18 $65,658 - $93,948
4,053 Added 16.66%
28,385 $609,000
Q3 2023

Nov 13, 2023
BUY
$20.63 - $30.17 $2,248 - $3,288
109 Added 0.45%
24,332 $501,000
Q2 2023

Aug 10, 2023
BUY
$23.37 - $32.96 $45,267 - $63,843
1,937 Added 8.69%
24,223 $714,000
Q1 2023

May 11, 2023
SELL
$21.91 - $32.67 $101,268 - $151,000
-4,622 Reduced 17.18%
22,286 $513,000
Q4 2022

Feb 02, 2023
BUY
$26.28 - $33.92 $108,247 - $139,716
4,119 Added 18.07%
26,908 $748,000
Q3 2022

Nov 04, 2022
BUY
$25.97 - $38.53 $15,971 - $23,695
615 Added 2.77%
22,789 $700,000
Q2 2022

Aug 01, 2022
SELL
$20.88 - $35.19 $202,682 - $341,589
-9,707 Reduced 30.45%
22,174 $653,000
Q1 2022

May 10, 2022
SELL
$29.0 - $47.27 $218,109 - $355,517
-7,521 Reduced 19.09%
31,881 $1.03 Million
Q4 2021

Feb 08, 2022
SELL
$42.59 - $55.02 $18,526 - $23,933
-435 Reduced 1.09%
39,402 $1.76 Million
Q3 2021

Nov 12, 2021
SELL
$48.48 - $78.23 $267,852 - $432,220
-5,525 Reduced 12.18%
39,837 $2.01 Million
Q2 2021

Aug 13, 2021
BUY
$50.3 - $78.44 $592,785 - $924,415
11,785 Added 35.1%
45,362 $3.56 Million
Q1 2021

May 14, 2021
BUY
$53.8 - $81.53 $61,278 - $92,862
1,139 Added 3.51%
33,577 $1.92 Million
Q4 2020

Feb 09, 2021
BUY
$36.89 - $93.56 $282,245 - $715,827
7,651 Added 30.87%
32,438 $2.72 Million
Q3 2020

Nov 13, 2020
SELL
$23.13 - $38.84 $14,733 - $24,741
-637 Reduced 2.51%
24,787 $888,000
Q2 2020

Aug 03, 2020
BUY
$16.01 - $28.82 $146,411 - $263,558
9,145 Added 56.18%
25,424 $615,000
Q1 2020

May 15, 2020
SELL
$14.2 - $27.98 $156,015 - $307,416
-10,987 Reduced 40.3%
16,279 $285,000
Q4 2019

Feb 12, 2020
SELL
$14.4 - $19.99 $59,385 - $82,438
-4,124 Reduced 13.14%
27,266 $475,000
Q3 2019

Nov 12, 2019
SELL
$15.32 - $21.92 $19,900 - $28,474
-1,299 Reduced 3.97%
31,390 $481,000
Q2 2019

Aug 13, 2019
SELL
$18.5 - $28.14 $83,657 - $127,249
-4,522 Reduced 12.15%
32,689 $679,000
Q1 2019

May 15, 2019
BUY
$17.99 - $24.65 $4,065 - $5,570
226 Added 0.61%
37,211 $864,000
Q4 2018

Feb 14, 2019
BUY
$13.88 - $21.75 $513,351 - $804,423
36,985 New
36,985 $764,000

Others Institutions Holding DNLI

# of Institutions
215
Shares Held
121M
Call Options Held
127K
Put Options Held
38.3K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.84B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email